First line nucleos(t)ide analog monotherapy is more cost-effective than combination strategies in hepatitis B e antigen-positive chronic hepatitis B patients in China
Abstract. Background:. Nucleos(t)ide analog (NA) in combination with peginterferon (PegIFN) therapy in patients with hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB) shows better effectiveness than NA monotherapy in hepatitis B surface antigen loss, termed “functional cure,” based on...
| الحاوية / القاعدة: | Chinese Medical Journal |
|---|---|
| المؤلفون الرئيسيون: | , , , , , , , , , , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
Wolters Kluwer
2019-10-01
|
| الوصول للمادة أونلاين: | http://journals.lww.com/10.1097/CM9.0000000000000445 |